ESR1 and neoplasm: Irshad et al. found that posterior shadowing is strongly associated with Estrogen Receptor-positive (ER+) and low-grade tumours, whereas posterior enhancement is strongly associated with high-grade tumours and a moderate risk of being receptor negativity9.